Mid-Atlantic Manufacturing Activity Still Struggling to Rebound, Richmond Fed Says
By Joshua Kirby
Factory activity slumped more sharply in the U.S. mid-Atlantic region this month, suggesting manufacturers are still struggling under high interest rates.
The Fifth District Survey of Manufacturing Activity's index for September edged down to minus 21 from minus 19 in August, hitting the worst reading since the pandemic days of mid-2020.
A reading of zero in the index represents an equal number of firms reporting increases and decreases in activity, meaning a negative reading marks a more negative result across respondents.
There was sign of some recovery in demand, with the index of new orders climbing to minus 23 from minus 26. However, the gauge of employment dropped sharply, to minus 22 from minus 15 previously, pointing to a tightening in the jobs market.
It suggests manufacturing firms are yet to see the benefit of easing borrowing costs after the Federal Reserve moved to cut its main interest rate by a half-point last week.
The index is compiled by surveying 70 to 80 manufacturing firms across the Fifth Federal Reserve District, which comprises the District of Columbia, Maryland, North Carolina, South Carolina, Virginia and most of West Virginia.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
September 24, 2024 10:43 ET (14:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk